SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-101433
Filing Date
2020-04-08
Accepted
2020-04-08 16:46:08
Documents
5
Period of Report
2020-04-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d904700d8k.htm 8-K 40767
2 EX-5.1 d904700dex51.htm EX-5.1 13515
3 EX-10.1 d904700dex101.htm EX-10.1 14341
4 GRAPHIC g904700g56d94.jpg GRAPHIC 1882
5 GRAPHIC g904700g61e67.jpg GRAPHIC 2446
  Complete submission text file 0001193125-20-101433.txt   76193
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 20782366
SIC: 3841 Surgical & Medical Instruments & Apparatus